Zevra Therapeutics, Inc. ZVRA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s total liabilities & equity?
- Zevra Therapeutics, Inc. (ZVRA) reported total liabilities & equity of $278.58M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Zevra Therapeutics, Inc.'s total liabilities & equity increased by 61.3% year-over-year, from $172.71M to $278.58M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total liabilities & equity has grown at a 91.0% compound annual growth rate (CAGR), from $11.21M to $284.73M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.